T10669	GO:0007605 174 181	hearing
T10670	GO:0007567 474 482	pathways
T10671	GO:1990113 822 825	air
T10672	GO:0007601 1596 1600	will
T10673	GO:0007605 2537 2544	hearing
T10674	GO:0000239 2687 2696	pathogens
T10675	GO:0016265 2866 2877	persistence
T10676	66 3077 3078	.
T10677	GO:0007612 3179 3184	large
T10678	0006000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000 3548 3550	an
T10679	GO:0065007 3700 3709	component
T10680	GO:0070268 3934 3944	compounded
T10681	0088888880000008888000000888800000008880000808008880000800880008000800800800080080080080080080080080 4118 4120	as
T10682	030 4306 4308	in
T10683	GO:0007565 4489 4497	programs
T10684	GO:0007067 4757 4766	mutations
T10685	66 4931 4932	.
T10686	GO:0007567 5042 5050	proteins
T10687	GO:0007631 5277 5285	involved
T10688	GO:0007605 5414 5420	having
T10689	GO:0007567 14215 14224	postnatal
T10690	GO:0007567 15124 15130	polyps
T10691	GO:0050820 15503 15505	TB
T10692	:0065006 16118 16120	OM
T10693	8888 16275 16278	180
T10694	GO:0007601 16576 16581	flora
T10695	GO:0009553 17050 17063	multinucleate
T10696	0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000 17484 17485	(
T10697	GO:0050909 18068 18071	the
T10698	GO:0007179 24191 24206	TGF - Î² signaling
T10699	GO:0065007 24325 24335	control of
T10700	GO:0008283 24336 24352;24353 24370	cell development ... proliferation
T10701	GO:0007499 24436 24463	Evi1 in the transcriptional
T10702	GO:0007568 24570 24573	[ 26
T10703	GO:0007631 24573 24575	].
T10704	GO:0007090 24648 24669	second of these three
T10705	GO:0042535 24751 24778	residues within these three
T10706	GO:0003058 24940 24960	contact residue , and
T10707	GO:0060601 25114 25136	function of the second
T10708	GO:0016441 25233 25240	- finger
T10709	GO:0030540 25241 25252;25253 25264	domain that ... involved
T10710	GO:0042334 25335 25363	the phenotype of Evi1tm1Mmor
T10711	GO:0042977 25435 25457	allele for the longest
T10712	GO:0006309 25580 25603	D3 cells with chimaeras
T10713	GO:0048770 25710 25743	backgrounds between Evi1tm1Mmor /+
T10714	GO:0044662 25892 25910	- function effects .
T10715	GO:0002575 25968 25996	between these possibilities .
T10716	GO:0046593 26059 26074	OM by more than
T10717	GO:0070945 26240 26271	neutrophil leukocytes during OM
T10718	GO:0051458 26374 26394	myeloid leukemia [ 27
T10719	GO:0000174 26466 26494	inositol triphosphate type 2
T10720	GO:0012502 26608 26612	- phe
T10721	GO:0051775 26613 26631;26632 26643	receptor signaling ... response
T10722	GO:0070277 26737 26758	when OM first appears
T10723	GO:0007586 26882 26890	does not
T10724	GO:0071167 26891 26900;26901 26925	result in ... neutrophilia
T10725	GO:0009453 27014 27028	Jbo /+ and wild
T10726	GO:0065007 30361 30371	regulation
T10727	GO:0007613 30458 30465	members
T10728	0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000 30704 30705	a
T10729	GO:0007567 30821 30827	normal
T10730	0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000 31002 31003	a
T10731	GO:0007608 31137 31139	on
T10732	11 31369 31370	-
T10733	GO:0043277 31604 31615	Pasteurella
T10734	0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000 31717 31718	/
T10735	600000000006 31968 31970	of
T10736	11 32140 32141	-
T10737	GO:0016265 32340 32350	maintained
T10738	GO:0060004 32443 32449	reflex
